We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy

EP38446
Abstract: Charge variants related to glycosylation, C terminal processing, deamidation or glycation often occur in mAb based biotherapeutics. Routine charge variant analysis is conducted throughout manufacturing to evaluate quality attributes that could affect the final drug quality, safety, and potency. Monoclonal antibody Cetuximab has four N glycan sites with two sites on each heavy chain located in the Fc and CH 1 domain Capillary zone electrophoresis (CZE) coupled with high resolution mass spectrometry provides a powerful MS hyphenated alternative to identify charge variants present in complex biopharmaceuticals. ZipChip is a microfluidic device integrating CZE with electrospray ionization. In this work, ZipChip is coupled to Bruker’s Ultra High Resolution QTOF maXis II mass spectrometer for deep profiling of Cetuximab charge variants.
Summary: In this work, ZipChip is coupled to Bruker’s Ultra High Resolution QTOF maXis II mass spectrometer for deep profiling of Cetuximab charge variants.
Summary: In this work, ZipChip is coupled to Bruker’s Ultra High Resolution QTOF maXis II mass spectrometer for deep profiling of Cetuximab charge variants.
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Related Posters
Pharmacokinetics modeling and optimal dose prediction for a bispecific antibody against CD40 and PD1
Alexandra Diakonova, Oleg Demin Jr, Dmitry Shchelokov, Oleg Demin
Introduction of Polyethylene Glycol (PEG)
Alex Brown
Nitrogen metabolism pathway
BOC Sciences
Application review of pseudoUridine and its derivatives
BOC Sciences
Science lab Report on H2N2 is the new wily virus driving people to hospitals
Anmol Chipa